Unsere Erfahrung mit β-Thalassämie in der Schwangerschaft beschränkt sich auf 2 seltene Fälle. Die erste Patientin litt an β⁰/β+-Thalassämie und erhielt 300 ml/Monat Erythrozytenkonzentrat und Deferoxamin subkutan. Während der Schwangerschaft wurde sie mit 300 ml/ Woche Erythrozytenkonzentrat behandelt und durch Kaiserschnitt von einem gesunden Kind entbunden. Die zweite Patientin litt bis 1985 an β-Thalassaemia major. Sie erhielt häufig Bluttransfusionen, war aber gegen Deferoxamin allergisch. Danach war bei ihr eine Knochenmarktransplantation erfolgreich. Ihre unauffällige Schwangerschaft endete am Termin mit der Spontangeburt eines gesunden Kindes.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.